RZLT
$3.46
Rezolute
($.08)
(2.26%)
RZLT
Earnings Whisper ®
N/A
3rd Quarter March 2026
Consensus:  ($0.13)
Revenue:  N/A
Thursday
May 14
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RZLT reports earnings?
Beat
Meet
Miss

Where is RZLT's stock price going from here?
Up
Flat
Down
Stock chart of RZLT
Analysts
Summary of analysts' recommendations for RZLT
Score
Grade
Pivots
Resistance
$3.79
$3.72
$3.59

$3.52

Support
$3.39
$3.32
$3.19
Tweet
Growth
Description
Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States.
›